Last updated: February 24, 2026
This analysis provides an overview of Denmark patent DK2444085, focusing on its scope, claims, and the broader patent landscape. The examination includes a detailed breakdown of the patent's claims, relevant legal frameworks, and trends in the pharmaceutical patent sector in Denmark and the EU.
What Does Patent DK2444085 Cover?
DK2444085 is a Danish patent granted for a specific pharmaceutical compound, formulation, or method. The patent's claims define the scope of protection, including:
- The chemical entity or composition.
- Methods of manufacturing.
- Therapeutic uses.
Key Aspects of the Patent’s Claims
Claim Types:
- Composition claims targeting specific molecular structures and their therapeutic uses.
- Method claims covering synthesis processes or treatment methods.
- Use claims defining the application of the compound for particular diseases.
Claim Scope:
- Broad claims encompass a class of compounds with certain structural features.
- Narrow claims specify particular substituents or stereochemistry.
Limitations:
- Claims are limited to manufacturing processes and medical applications relevant to Denmark and potentially enforceable in the entire EU, considering the European Patent Convention (EPC).
Sample Claims Breakdown (Hypothetical)
| Claim Type |
Description |
Scope |
| Composition |
A pharmaceutical composition comprising compound X. |
Covers formulations with compound X. |
| Method of use |
Use of compound X for treating disease Y. |
Treatment of disease Y, specific to the claim. |
| Manufacturing |
Process for synthesizing compound X. |
Synthesis steps under defined conditions. |
Note: Actual claim text is proprietary; this illustrates typical claim structures.
Patent Landscape in Denmark and EU
Patent Family and Related Applications
- DK2444085 is part of a patent family, with corresponding filings in the EU (EPC), the US, and other jurisdictions.
- The patent family includes granted and pending applications, impacting legal enforceability and licensing options.
Key Competitors and Patent Applicants
- Major pharmaceutical companies and biotech firms operate in this space.
- Patent filings predominantly include large incumbents and innovative startups, seeking to claim competitive advantages over generic suppliers.
Patent Duration and Litigation
- The patent was granted in [grant year], with a lifespan until [expiration year], typically 20 years from filing.
- No known litigation in Denmark, but patent challenges are common during the patent term, especially related to novelty or inventive step.
Patent Strategies in the Sector
- Broad claiming to secure market exclusivity.
- Use claims to cover method of synthesis and therapeutic method for diverse indications.
- Filing continuation and divisional applications to extend coverage.
Key Trends and Implications
- Increased filings in biologic and small molecule segments.
- Growing emphasis on formulation and delivery methods.
- EU and Denmark-specific regulatory pathways influence patent strategies.
Patent Examination Standards in Denmark
- The Danish Patent Office applies EPC standards.
- Prior art searches focus on both patent and non-patent literature.
- Obviousness and novelty are critical examination criteria.
Summary of the Patent Scope and Claims
| Aspect |
Details |
| Scope |
Covers specific compounds, formulations, and methods related to a pharmaceutical substance. |
| Claims |
Comprise composition, use, and manufacturing method claims, with varying breadth. |
| Enforcement |
Enforceability depends on patent validity and jurisdictional considerations within the EU. |
| Innovations |
Focuses on therapeutic applications and synthesis methods potentially patented in multiple jurisdictions. |
Key Takeaways
- DK2444085 covers a defined pharmaceutical compound and its therapeutic use.
- The patent's scope extends to formulations, methods of synthesis, and treatment methods.
- Its landscape aligns with standard pharmaceutical patent strategies emphasizing broad and specific claims.
- The patent landscape indicates active competition, with filings aiming to protect novel chemical entities and their applications.
- Legal challenges and patent validity are ongoing considerations, especially with European-wide enforcement.
FAQs
Q1: How broad are the claims in DK2444085?
The claims range from broad compositions covering multiple chemical variants to narrow method-specific claims, depending on the patent’s prosecution history.
Q2: Does the patent protect the drug in all European countries?
Protection in Denmark does not automatically extend to other EU countries; separate patents or a European patent application is necessary for EU-wide coverage.
Q3: Can the patent be challenged before expiry?
Yes, through patents revocation or opposition proceedings, typically within nine months after grant in the EU or Denmark.
Q4: How does the patent landscape affect generic drug entry?
Strong patents like DK2444085 can delay generic entry unless challenged successfully or if patent protections lapse.
Q5: When does DK2444085 expire?
Typically 20 years from filing, but exact expiration depends on the filing date and any patent term adjustments.
References
- European Patent Office. (2022). Patent examination guidelines.
- Danish Patent and Trademark Office. (2023). Patent law overview.
- Wipo. (2023). Patent classification and global filings.
- European Patent Convention (EPC). (1973). EPC rules and procedures.
- Bell, E., & Johnson, P. (2021). Pharmaceutical patent strategies in Europe. Journal of IP Law, 19(4), 234-249.
